G

Grifols SA

D

GRFS

USD

0.335

(3.833%)

Market Closed

46,736.00

حجم التداول

0.51

الربح لكل سهم

-

العائد الربحي

33.874

P/E

6,167,634,980.93

حجم السوق

اليوم

3.8330%

1 اسبوع

-0.384%

1 شهر

26.569%

6 اشهر

49.629%

12 اشهر

-6.971%

بداية السنة

-21.497%

كل الوقت

-43.175%

أصول ذات صلة

Title:
Grifols SA

Sector:

Healthcare

Industry:

Drug Manufacturers - General

As a vertically integrated plasma derivative producer, Spain-based Grifols collects plasma and then manufactures and sells plasma-derived products globally. By acquiring Talecris in 2011, Grifols dramatically expanded its plasma-derived product portfolio, and following the firm's Biotest acquisition in April 2022, the biopharma business contributed 84% of sales in 2023. Grifols also has smaller segments including diagnostics (10% of sales) and biosupplies.

هل تحتاج مساعدة او لديك استفسار؟

تواصل معنا